{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:27:22Z","timestamp":1789345642307,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejpb.2018.11.018","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T10:44:34Z","timestamp":1542883474000},"page":"96-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis"],"prefix":"10.1016","volume":"134","author":[{"given":"Raghda","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma N.","family":"Tammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara El","family":"Safy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-4219","authenticated-orcid":false,"given":"Mohammad","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Asimakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.11.018_b0005","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2741\/reeves","article-title":"Activation of hepatic stellate cells\u2014a key issue in liver fibrosis","volume":"7","author":"Reeves","year":"2002","journal-title":"Front Biosci."},{"key":"10.1016\/j.ejpb.2018.11.018_b0010","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2018.11.018_b0015","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1038\/s41598-017-09673-5","article-title":"Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-\u03b21\/Smads and PI3K\/Akt pathways","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2018.11.018_b0020","doi-asserted-by":"crossref","first-page":"e83391","DOI":"10.1371\/journal.pone.0083391","article-title":"Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3","volume":"9","author":"Wilson","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2018.11.018_b0025","doi-asserted-by":"crossref","first-page":"15713","DOI":"10.1073\/pnas.1522163112","article-title":"BRD4 is a novel therapeutic target for liver fibrosis","volume":"112","author":"Ding","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2018.11.018_b0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/egh.11.92","article-title":"Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques","volume":"6","author":"Tacke","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00109-017-1593-6","article-title":"miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7","volume":"96","author":"Yu","year":"2018","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejpb.2018.11.018_b0040","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0168-8278(03)00051-5","article-title":"Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells","volume":"38","author":"Rombouts","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0045","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells","volume":"53","author":"Trebicka","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2014.08.013","article-title":"Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C","volume":"62","author":"Simon","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0055","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","author":"Abraldes","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2018.11.018_b0060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.115.307004","article-title":"Bromodomain-containing protein 4 novelty and significance: the epigenetic origin of pulmonary arterial hypertension","volume":"117","author":"Meloche","year":"2015","journal-title":"Circul. Res."},{"key":"10.1016\/j.ejpb.2018.11.018_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molcel.2016.08.023","article-title":"Bromodomain inhibitors correct bioenergetic deficiency caused by mitochondrial disease complex I mutations","volume":"64","author":"Barrow","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejpb.2018.11.018_b0070","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature12147","article-title":"The bromodomain protein Brd4 insulates chromatin from DNA damage signalling","volume":"498","author":"Floyd","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2018.11.018_b0075","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/nn.4095","article-title":"BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice","volume":"18","author":"Korb","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejpb.2018.11.018_b0080","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jcmm.13059","article-title":"The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo","volume":"21","author":"Jostes","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejpb.2018.11.018_b0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ddtec.2016.06.004","article-title":"Clinical trials for BET inhibitors run ahead of the science","volume":"19","author":"Andrieu","year":"2016","journal-title":"Drug Discov. Today: Technol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13287-016-0278-3","article-title":"BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells","volume":"7","author":"Alghamdi","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejpb.2018.11.018_b0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1166\/jbn.2015.2017","article-title":"Biodegradable particulate carrier formulation and tuning for targeted drug delivery","volume":"11","author":"Tammam","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00033","article-title":"Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis","volume":"7","author":"Schon","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-1-1","article-title":"Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review","volume":"1","author":"Braet","year":"2002","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0110","doi-asserted-by":"crossref","DOI":"10.3791\/52698","article-title":"Le Couteur DG. A standardized method for the analysis of liver sinusoidal endothelial cells and their fenestrations by scanning electron microscopy","author":"Cogger","year":"2015","journal-title":"J. Visual. Exp.: JoVE."},{"key":"10.1016\/j.ejpb.2018.11.018_b0115","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis\u2013current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0120","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","volume":"61","author":"DeLeve","year":"2015","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.ejpb.2018.11.018_b0125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/hep.1840170520","article-title":"Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis","volume":"17","author":"Mori","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.ejpb.2018.11.018_b0130","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1021\/acs.molpharmaceut.5b00478","article-title":"Chitosan nanoparticles for nuclear targeting: the effect of nanoparticle size and nuclear localization sequence density","volume":"12","author":"Tammam","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.11.018_b0135","first-page":"2635","article-title":"A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells","volume":"9","author":"Zhou","year":"2015","journal-title":"Drug Design, Develop. Therapy"},{"key":"10.1016\/j.ejpb.2018.11.018_b0140","series-title":"Section 5 \u2013 Laboratory Diagnosis and Test Protocols. Kirk & Bistner's Handbook of Veterinary Procedures and Emergency Treatment","first-page":"551","author":"Ford","year":"2012"},{"key":"10.1016\/j.ejpb.2018.11.018_b0145","series-title":"Isolation and Culture of Primary Murine Hepatic Stellate Cells. Fibrosis","first-page":"165","author":"Weiskirchen","year":"2017"},{"key":"10.1016\/j.ejpb.2018.11.018_b0150","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijbiomac.2015.09.021","article-title":"A high throughput method for quantification of cell surface bound and internalized chitosan nanoparticles","volume":"81","author":"Tammam","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0160","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/labinvest.2012.106","article-title":"Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats","volume":"92","author":"Klein","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejpb.2018.11.018_b0165","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.bbamcr.2016.07.006","article-title":"Adenoviral CCN gene transfers induce in vitro and in vivo endoplasmic reticulum stress and unfolded protein response","volume":"1863","author":"Borkham-Kamphorst","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.ejpb.2018.11.018_b0170","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Yanguas","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0175","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bbamem.2007.03.027","article-title":"Reker-Smit C, Terpstra P, Poelstra K. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats","volume":"1768","author":"Adrian","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"10.1016\/j.ejpb.2018.11.018_b0180","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.3748\/wjg.v20.i23.7242","article-title":"Nanotechnology applications for the therapy of liver fibrosis","volume":"20","author":"Giannitrapani","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.ejpb.2018.11.018_b0185","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nnano.2013.181","article-title":"Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology","volume":"8","author":"Tenzer","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0190","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1021\/nn505166x","article-title":"Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2018.11.018_b0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1166\/jbn.2012.1403","article-title":"Preparation and biopharmaceutical evaluation of tacrolimus loaded biodegradable nanoparticles for liver targeting","volume":"8","author":"Tammam","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0200","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/mp2005615","article-title":"Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery","volume":"9","author":"Amoozgar","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.11.018_b0205","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2005.08.027","article-title":"Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems","volume":"44","author":"Adrian","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0210","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.107.122481","article-title":"Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats","volume":"322","author":"Du","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2018.11.018_b0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2011.12.023","article-title":"Lu W-y. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor\u2013beta on hepatic fibrosis in rats","volume":"159","author":"Li","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.11.018_b0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejps.2013.11.017","article-title":"Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats","volume":"52","author":"Yang","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.11.018_b0225","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2004.03.010","article-title":"Severe pulmonary pathology after intravenous administration of vectors in cirrhotic rats","volume":"9","author":"Smith","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2018.11.018_b0230","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1021\/acsnano.5b01326","article-title":"Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake","volume":"9","author":"Pelaz","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2018.11.018_b0235","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1016\/j.bmc.2017.06.040","article-title":"Nanoparticle-macrophage interactions: a balance between clearance and cell-specific targeting","volume":"25","author":"Rattan","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejpb.2018.11.018_b0240","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ppsc.201300357","article-title":"The cellular interactions of PEGylated gold nanoparticles: effect of PEGylation on cellular uptake and cytotoxicity","volume":"31","author":"Soenen","year":"2014","journal-title":"Part. Part. Syst. Char."},{"key":"10.1016\/j.ejpb.2018.11.018_b0245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A\u2013coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.colsurfb.2016.02.029","article-title":"The impact of retinol loading and surface charge on the hepatic delivery of lipid nanoparticles","volume":"141","author":"Pan","year":"2016","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2018.11.018_b0255","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jcb.10703","article-title":"Hepatic stellate cells uptake of retinol associated with retinol-binding protein or with bovine serum albumin","volume":"90","author":"Fortuna","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejpb.2018.11.018_b0260","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1073\/pnas.90.8.3616","article-title":"Transfer of retinol-binding protein from HepG2 human hepatoma cells to cocultured rat stellate cells","volume":"90","author":"Senoo","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2018.11.018_b0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2017.02.029","article-title":"The effect of nanoparticle size and NLS density on nuclear targeting in cancer and normal cells; impaired nuclear import and aberrant nanoparticle intracellular trafficking in glioma","volume":"253","author":"Tammam","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.11.018_b0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.05.031","article-title":"Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue","volume":"146","author":"Abbas","year":"2016","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2018.11.018_b0275","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1002\/anie.201003445","article-title":"Ligand-clustered \u201cPatchy\u201d nanoparticles for modulated cellular uptake and in vivo tumor targeting","volume":"49","author":"Poon","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejpb.2018.11.018_b0280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nano.2012.05.015","article-title":"Effect of ligand density, receptor density, and nanoparticle size on cell targeting","volume":"9","author":"Elias","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejpb.2018.11.018_b0285","article-title":"Effects of polyethylene glycol spacer length and ligand density on folate receptor targeting of liposomal Doxorubicin in vitro","author":"Kawano","year":"20112011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.11.018_b0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-3659(03)00295-5","article-title":"Controlled targeting of liposomal doxorubicin via the folate receptor in vitro","volume":"92","author":"Saul","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.11.018_b0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2005.01.012","article-title":"Folate targeting of drug carriers: a mathematical model","volume":"104","author":"Ghaghada","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.11.018_b0300","doi-asserted-by":"crossref","first-page":"11306","DOI":"10.1021\/ja1043177","article-title":"The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies","volume":"132","author":"Wang","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2018.11.018_b0305","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1021\/acs.jpcc.5b11059","article-title":"Nanoparticle multivalency directed shifting of cellular uptake mechanism","volume":"120","author":"Dalal","year":"2016","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.ejpb.2018.11.018_b0310","doi-asserted-by":"crossref","first-page":"G110","DOI":"10.1152\/ajpgi.00412.2010","article-title":"Hepatic stellate cells require a stiff environment for myofibroblastic differentiation","volume":"301","author":"Olsen","year":"2011","journal-title":"Am. J. Physiol-Gastrointestinal Liver Physiol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0315","series-title":"Plasma Retinol-Binding Protein: Structure and Interactions with Retinol, Retinoids, and Transthyretin. Vitamins & Hormones","first-page":"271","author":"Zanotti","year":"2004"},{"key":"10.1016\/j.ejpb.2018.11.018_b0320","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hep.23271","article-title":"Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease","volume":"51","author":"Bell","year":"2010","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.ejpb.2018.11.018_b0325","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer","volume":"359","author":"Petricoin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2018.11.018_b0330","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/TP.0b013e318191c68d","article-title":"Proteomic analysis of HCV cirrhosis and HCV-induced HCC: Identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation","volume":"87","author":"Mas","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ejpb.2018.11.018_b0335","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1021\/pr800197z","article-title":"A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma","volume":"7","author":"Chaerkady","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejpb.2018.11.018_b0340","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cgh.2008.12.031","article-title":"Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease","volume":"7","author":"Nobili","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0345","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2265.2007.03072.x","article-title":"Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease","volume":"68","author":"Seo","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0350","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1038\/s41598-017-03096-y","article-title":"Retinol-binding protein-4 expression marks the short-term mortality of critically ill patients with underlying liver disease: Lipid, but not glucose, matters","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2018.11.018_b0355","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s10620-007-9997-8","article-title":"Comparative studies on expression of \u03b1-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C","volume":"53","author":"Chu","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejpb.2018.11.018_b0360","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/15592294.2016.1265710","article-title":"Bromodomain inhibitors and cancer therapy: from structures to applications","volume":"12","author":"P\u00e9rez-Salvia","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/j.ejpb.2018.11.018_b0365","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrc3256","article-title":"BET domain co-regulators in obesity, inflammation and cancer","volume":"12","author":"Belkina","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2018.11.018_b0370","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2018.11.018_b0375","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature.2016.19189","article-title":"Scientists in the dark after fatal French clinical trial: knowledge about the drug's structure would help researchers understand what happened","volume":"529","author":"Butler","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2018.11.018_b0380","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI114943","article-title":"Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production","volume":"86","author":"Davis","year":"1990","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejpb.2018.11.018_b0385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bj2780043","article-title":"Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation","volume":"278","author":"Davis","year":"1991","journal-title":"Biochem. J"},{"key":"10.1016\/j.ejpb.2018.11.018_b0390","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jcp.22063","article-title":"Downregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation-related protein (ADRP)","volume":"223","author":"Lee","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0395","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.intimp.2014.09.007","article-title":"Toll like receptor 4 (TLR4) mediates the stimulating activities of chitosan oligosaccharide on macrophages","volume":"23","author":"Zhang","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0400","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.carbpol.2010.08.071","article-title":"The effects of chitosan oligosaccharide on the activation of murine spleen CD11c+ dendritic cells via Toll-like receptor 4","volume":"83","author":"Dang","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2018.11.018_b0405","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ijbiomac.2016.02.015","article-title":"Chitosan nanoparticles reduce LPS-induced inflammatory reaction via inhibition of NF-\u03baB pathway in Caco-2 cells","volume":"86","author":"Tu","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2018.11.018_b0410","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/md13042158","article-title":"The potential of chitosan and its derivatives in prevention and treatment of age-related diseases","volume":"13","author":"Kerch","year":"2015","journal-title":"Mar Drugs"},{"key":"10.1016\/j.ejpb.2018.11.018_b0415","article-title":"Chitosan immunomodulatory properties: prespective on the impact of structural propertie and dosage","volume":"4","author":"Fong","year":"2017","journal-title":"Future Sci."},{"key":"10.1016\/j.ejpb.2018.11.018_b0420","doi-asserted-by":"crossref","first-page":"155","DOI":"10.21608\/bvmj.2015.32730","article-title":"Hypolipidemic and anti-inflammatory effect of chitosan in experimental induced non -alcoholic fatty liver disease in rats","volume":"28","author":"AboZaid","year":"2015","journal-title":"Benha Veterinary Med. J."},{"key":"10.1016\/j.ejpb.2018.11.018_b0425","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.kjms.2014.02.003","article-title":"Protective effect of chitosan treatment against acetaminophen induced hepatotoxcity","volume":"30","author":"Ozcelik","year":"2014","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.ejpb.2018.11.018_b0430","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11802-014-2511-y","article-title":"Effects of sulfate chitosan derivatives on nonalcoholic fatty liver disease","volume":"13","author":"Yu","year":"2014","journal-title":"J. Ocean Univ. China"},{"key":"10.1016\/j.ejpb.2018.11.018_b0435","first-page":"3211","article-title":"Therapeutic effect of chitosan on CCl(4)-induced hepatic fibrosis in rats","volume":"18","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.ejpb.2018.11.018_b0440","article-title":"Possible synergistic effect and antioxidant properties of chitosan nanoparticles and quercetin against carbon tetrachloride induced hepatotoxcity in rats","volume":"5","author":"Denshary","year":"2015","journal-title":"Soft Nanosci. Lett."},{"key":"10.1016\/j.ejpb.2018.11.018_b0445","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejpb.2018.05.027","article-title":"Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: cellular location dependent-action of lactoferrin","volume":"129","author":"Tammam","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118307641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118307641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T17:23:57Z","timestamp":1720805037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118307641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":89,"alternative-id":["S0939641118307641"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.018","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}